GPR39 and Cognitive impairment: We recently reported that GPR39 is an oxylipins receptor (Alkayed et al., 2022); therefore, we report here valuable and unique oxylipins data that point to specific pathways altered in brain and plasma by HFD and GPR39 deletion, as potential mediators of cognitive impairment in these models.